A dual GIP and GLP-1 receptor agonist peptide supplied as a sterile lyophilized powder for research and formulation development. Each batch is produced under controlled conditions and shipped with a certificate of analysis. Reconstitute in sterile water or buffer per your protocol.
首页 / 产品 / Weight Management & Metabolic Regulation
Weight Management & Metabolic Regulation
Tirzepatide
别名: LY3298176, GLP-1/GIP dual receptor agonist
- CAS2023788-19-2
- 分子式C225H348N48O68
- 分子量4813.45 g/mol
- EC / EINECSNot applicable (synthetic)
包装与库存
价格面议| Select | 货号 | 包装规格 | 每箱 | 库存状态 | Price |
|---|---|---|---|---|---|
| TZ05 | 5 mg/vial | 10 vials/box | On request | 询价 | |
| TZ10 | 10 mg/vial | 10 vials/box | On request | 询价 | |
| TZ15 | 15 mg/vial | 10 vials/box | On request | 询价 | |
| TZ30 | 30 mg/vial | 10 vials/box | On request | 询价 |
将所需规格加入询价单,我们团队将跟进报价与交期。
| CAS | 2023788-19-2 |
|---|---|
| 线性分子式 | C225H348N48O68 |
| 分子量 | 4813.45 g/mol |
| 纯度 / 等级 | ≥99%, GMP Research Grade, Lyophilized |
| EC / EINECS | Not applicable (synthetic) |
| 别名 | LY3298176, GLP-1/GIP dual receptor agonist |
| 储存条件 | Store at 2–8°C, protect from light |